EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Solid Lipid Nanoparticles as Dry Powder: Characterization and Formulation Considerations

Debora Santonocito iD, Maria Grazia Sarpietro iD, Francesco Castelli, Maria Rosaria Lauro iD, Cristina Torrisi, Stefano Russo iD, Carmelo Puglia iD

Molecules · 2023

DOI: 10.3390/molecules28041545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Debora Santonocito und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug and Health Science, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy. Hauptthemen laut MEDLINE: Nanoparticles. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Funding for University of Catania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solid lipid nanoparticles (SLNs) are lipid-based colloidal systems used for the delivery of active compounds. Although SLNs have many benefits, they show important issues due to physical and chemical instability phenomena during storage. For these reasons, it is highly desirable to have a dried SLN formulation available. Therefore, the aim of the project was to identify suitable methods to obtain a dry powder formulation from an SLN suspension. The nanoparticle suspension was dried using both freeze- and spray-drying techniques. The suitability of these methods in obtaining SLN dry powders was evaluated from the analyses of nanotechnological parameters, system morphology and thermal behavior using differential scanning calorimetry. Results pointed out that both drying techniques, although at different yields, were able to produce an SLN dry powder suitable for pharmaceutical applications. Noteworthily, the freeze-drying of SLNs under optimized conditions led to a dry powder endowed with good reconstitution properties and technological parameters similar to the starting conditions. Moreover, freeze–thaw cycles were carried out as a pretest to study the protective effect of different cryoprotectants (e.g., glucose and mannitol with a concentration ranging from 1% to 10% w/v). Glucose proved to be the most effective in preventing particle growth during freezing, thawing, and freeze-drying processes; in particular, the optimum concentration of glucose was 1% w/v.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesPowdersParticle SizeDrug CompoundingFreeze DryingLiposomes

Stichwörter der Autor:innen

differential scanning calorimetryfreeze-dryingsolid lipid nanoparticlesspray-drying

Substanzen

PowdersLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Drug and Health Science, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
  • Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Italy.

ORCID-Profile: Debora Santonocito, Maria Grazia Sarpietro, Maria Rosaria Lauro, Stefano Russo, Carmelo Puglia

Förderung

  • Research Funding for University of Catania

Zitieren

APA

Santonocito, D., Sarpietro, M. G., Castelli, F., Lauro, M. R., Torrisi, C., Russo, S., & Puglia, C. (2023). Development of Solid Lipid Nanoparticles as Dry Powder: Characterization and Formulation Considerations. Molecules. https://doi.org/10.3390/molecules28041545

Vancouver

Santonocito D, Sarpietro MG, Castelli F, Lauro MR, Torrisi C, Russo S, et al. Development of Solid Lipid Nanoparticles as Dry Powder: Characterization and Formulation Considerations. Molecules. 2023. doi:10.3390/molecules28041545

BibTeX
@article{Santonocito2023,
  author = {Santonocito, Debora and Sarpietro, Maria Grazia and Castelli, Francesco and Lauro, Maria Rosaria and Torrisi, Cristina and Russo, Stefano and Puglia, Carmelo},
  title = {Development of Solid Lipid Nanoparticles as Dry Powder: Characterization and Formulation Considerations},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28041545}
}
Kostenlos starten →